In-Silico Analysis of Polyphenol Compounds in Pomegranate Fruit (Punica granatum L.) Peel Potential as type 2 Antidiabetes Mellitus
DOI:
https://doi.org/10.21580/wjc.v6i2.17692Keywords:
diabetes mellitus, pomegranate peel, PTP1B, polyphenols, in-silicoAbstract
Diabetes mellitus is a disease characterized by increased blood sugar levels due to insulin resistance caused by the uncontrolled expression of the protein tyrosine phosphatase 1B (PTP1B). Several compounds that inhibit PTP1B have been studied, including polyphenol. Many studies have been conducted on diabetes medicines based on natural ingredients, including the pomegranate fruits (Punica granatum L). This study aims to test the inhibitory activity of polyphenolic compounds in pomegranate peel (gallic acid, caffeic acid, ellagic acid, chlorogenic acid, apigenin, quercetin, pelargonidin, and cyanidin) against PTP1B through molecular docking. The 3D structures of polyphenolic compounds were obtained from the PubChem database, while PTP1B was from the Protein Data Base. Molecular docking simulations were carried out using AutoDock Vina and several supporting softwares, such as Biovia Discovery Studio Client 4.1, AutoDockTools 1.5.6, PyMOL, and LigPlot. Molecular docking results showed that polyphenolic compounds from pomegranate peel have good inhibitory potential against PTP1B. It is proven by the binding affinity value for PTP1B, which is low and negative, namely in the range -6.4 to -8.4 kcal/mol, and the inhibition constant in the range 0.69 to 20,12 µM. The presence of phenol and carboxylic acid groups in polyphenol compounds can strengthen ligand-protein complexes through hydrogen bonds, especially with the amino acid residues Gln221 and Cys215. The potential of polyphenolic compounds as antidiabetics is also supported by van der Waals interactions and π-π stacking interactions with PTP1B. Based on the molecular docking test that has been carried out, it can be concluded that the polyphenolic compounds in pomegranate peel have the potential to act as type 2 anti-diabetes mellitus.
Downloads
References
Bagri. Priyanka. Mohd. Ali. Vidhu Aeri. Malay Bhowmik. and Shahnaz Sultana. (2009). Antidiabetic Effect of Punica Granatum Flowers: Effect on Hyperlipidemia. Pancreatic Cells Lipid Peroxidation and Antioxidant Enzymes in Experimental Diabetes. Food and Chemical Toxicology. 47(1). 50–54.
Barik. Sisir Kumar. Budheswar Dehury. Wendy R. Russell. Kim M. Moar. Morven Cruickshank. Lorraine Scobbie. and Nigel Hoggard. (2020). Analysis of Polyphenolic Metabolites from in Vitro Gastrointestinal Digested Soft Fruit Extracts Identify Malvidin-3-Glucoside as an Inhibitor of PTP1B. Biochemical Pharmacology. 178(August). 1-53.
Chen. Tao. Meixiu Li. and Jingquan Liu. (2018). π–π Stacking Interaction: A Nondestructive and Facile Means in Material Engineering for Bioapplications. Crystal Growth & Design. 18 (5). 1–55.
Cho. N.H.. J.E. Shaw. S. Karuranga. Y. Huang. J.D. Da Rocha Fernandes. A.W. Ohlrogge. and B. Malanda. (2018). IDF Diabetes Atlas: Global Estimates of Diabetes Prevalence for 2017 and Projections for 2045. Diabetes Research and Clinical Practice. 138(April). 271–281.
Damián. M.. K.. Y. Salinas-Moreno. D. Milenkovic. L. Figueroa-Yáñez. E. Marino-Marmolejo. I. Higuera-Ciapara. A. Vallejo-Cardona. and E. Lugo-Cervantes. (2020). In Silico Analysis of Antidiabetic Potential of Phenolic Compounds from Blue Corn (Zea Mays L.) and Black Bean (Phaseolus Vulgaris L.). Heliyon. 6(3). 1-13.
Das. Swamamoni. and Gayatri Sama. (1970). Antidiabetic Action of Ethanolic Extracts of Punica Granatum Linn. in Alloxan-Induced Diabetic Albino Rats. Stamford Journal of Pharmaceutical Sciences. 2(1). 14–21.
Fourati. Mariam. Slim Smaoui. Hajer Ben Hlima. Khaoula Elhadef. Olfa Ben Braïek. Karim Ennouri. Ahlem Chakchouk Mtibaa. and Lotfi Mellouli. (2020). Bioactive Compounds and Pharmacological Potential of Pomegranate (Punica Granatum) Seeds - A Review. Plant Foods for Human Nutrition. 75(4). 77–86.
Gharib. Ehsan. and Shideh Montasser Kouhsari. (2019). Study of the Antidiabetic Activity of Punica Granatum L. Fruits Aqueous Extract on the Alloxan-Diabetic Wistar Rats. Iranian Journal of Pharmaceutical Research. 18(1). 358-368.
Guedes. Isabella A.. Camila S. De Magalhães. and Laurent E. Dardenne. (2014). Receptor–Ligand Molecular Docking. Biophysical Reviews. 6(1). 75–87.
Gull Hina. Ikram Aqsa. Khalil Anees Ahmed. Ahmed Zahoor and Nemat Arash. (2023). Assessing the multitargeted antidiabetic potential of three pomegranate peel-specific metabolites: An in silico and pharmacokinetics study. Food Sci Nutr.. 2023(00). 1–18.
Ha. Manh Tuan. Dong Hwa Park. Srijan Shrestha. Minji Kim. Jeong Ah Kim. Mi Hee Woo. Jae Sue Choi. and Byung Sun Min. (2018). PTP1B Inhibitory Activity and Molecular Docking Analysis of Stilbene Derivatives from the Rhizomes of Rheum Undulatum L. Fitoterapia. 131(November). 19–26.
Hartanti. I. R.. A. A. Putri. N. N. Auliya AS. A. L. Triadenda. E. Laelasari. C. Suhandi. and M. Muchtaridi. (2022). Molecular Docking Senyawa Xanton. Benzofenon. Dan Triterpenoid Sebagai Antidiabetes Dari Ekstrak Tumbuhan Garcinia cowa. Jurnal Kimia. January. 72.
Kementerian kesehatan Republik Indonesia. (2022). Tetap Produktif. Cegah. dan Atasi Diabetes Melitus. INFODATIN: Pusat Data dan Informasi Kementerian Kesehatan RI.
Kumar. Roshan. Purabi Saha. Yogendra Kumar. Soumitra Sahana. Anubhav Dubey. and Om Prakash. (2020). A Review On Diabetes Mellitus: Type1 & Type2. World Journal of Pharmacy and Pharmaceutical Sciences. 9(10). 38–50.
Maphetu. Nhlanhla. Jeremiah Oshiomame Unuofin. Nelisiwe Prenate Masuku. Chijioke Olisah. and Sogolo Lucky Lebelo. (2022). Medicinal Uses. Pharmacological Activities. Phytochemistry. and the Molecular Mechanisms of Punica Granatum L. (Pomegranate) Plant Extracts: A Review. Biomedicine & Pharmacotherapy. 153(September). 113-256.
Mohanty. Tanmayee. and Preetha Bhadra. (2020). In- Silico Analysis of Roselle (Hibiscus Sabdariffa L.) for Antidiabetic. Indian Journal of Natural Sciences. 10(60). 20764-20768.
Morris. G. M.. Huey. R.. & Olson. A. J. (2008). Using AutoDock for Ligand-Receptor Docking. Current Protocols in Bioinformatics. 8(14). 1-40.
Mutha. Rakesh E.. Anilkumar U. Tatiya. and Sanjay J. Surana. (2021). Flavonoids as Natural Phenolic Compounds and Their Role in Therapeutics: An Overview. Future Journal of Pharmaceutical Sciences. 7(1). 1-13.
Nge. S.T.. dkk. (2019). Analisis Senyawa Polifenol Ekstrak Kulit Buah dan Biji Delima (Punica granatum L). Jurnal Biotropikal Sains. 16(1). 14–19.
Padhi. Santwana. Amit Kumar Nayak. and Anindita Behera. (2020). Type II Diabetes Mellitus: A Review on Recent Drug Based Therapeutics. Biomedicine & Pharmacotherapy. 131(November). 1-23.
Proença. Carina. Marisa Freitas. Daniela Ribeiro. Joana L.C. Sousa. Félix Carvalho. Artur M.S. Silva. Pedro A. Fernandes. and Eduarda Fernandes. (2018). Inhibition of Protein Tyrosine Phosphatase 1B by Flavonoids: A Structure - Activity Relationship Study. Food and Chemical Toxicology. 111(January). 474–481.
Pujiastuti. Muazah Wahyu. and I Gusti Made Sanjaya. (2017). Penentuan Aktivitas Senyawa Turunan Mangiferin Sebagai Antidiabetes Pada Diabetes Mellitus Tipe 2 Secara In Silico Determination Of Mangiferin Derived Compounds As Antidiabetic For Type 2 Diabetes Mellitus With In Silico. UNESA Journal of Chemistry. 6(3). 172-176.
Ranjha. Muhammad Modassar Ali Nawaz. Bakhtawar Shafique. Lufeng Wang. Shafeeqa Irfan. Muhammad Naeem Safdar. Mian Anjum Murtaza. Muhammad Nadeem. Shahid Mahmood. Ghulam Mueen-ud-Din. and Hafiz Rehan Nadeem. (2023). A Comprehensive Review on Phytochemistry. Bioactivity and Medicinal Value of Bioactive Compounds of Pomegranate (Punica Granatum). Advances in Traditional Medicine. 23(1). 37–57.
Rath. Prangya. Anuj Ranjan. Arabinda Ghosh. Abhishek Chauhan. Manisha Gurnani. Hardeep Singh Tuli. Hamza Habeeballah. et al. (2022). Potential Therapeutic Target Protein Tyrosine Phosphatase-1B for Modulation of Insulin Resistance with Polyphenols and Its Quantitative Structure–Activity Relationship. Molecules. 27(7). 1-28.
Shaker. Bilal. Sajjad Ahmad. Jingyu Lee. Chanjin Jung. and Dokyun Na. (2021). In Silico Methods and Tools for Drug Discovery. Computers in Biology and Medicine. 137(October). 1-14.
Singh. B.. Singh. J. P.. Kaur. A.. & Singh. N. (2018). Phenolic compounds as beneficial phytochemicals in pomegranate (Punica granatum L.) peel: A review. Food Chemistry. 261(April). 75–86.
Srividya. N.. Haldipur A. C. and Sanjeevi C. B. (2023). Plant Foods and Their Phytochemicals as DPP IV and PTP1B Inhibitors for Blood Glucose Regulation: A Review. J. Indian Inst. Sci.. 103(1). 149–165.
Tanase. Corneliu. Sanda Coșarcă. and Daniela-Lucia Muntean. (2019). A Critical Review of Phenolic Compounds Extracted from the Bark of Woody Vascular Plants and Their Potential Biological Activity. Molecules. 24(6). 1-18.
Wu. Xian. Mingyue Song. Peiju Qiu. Fang Li. Minqi Wang. Jinkai Zheng. Qi Wang. Fei Xu. and Hang Xiao. (2018). A Metabolite of Nobiletin. 4′-Demethylnobiletin and Atorvastatin Synergistically Inhibits Human Colon Cancer Cell Growth by Inducing G0/G1 Cell Cycle Arrest and Apoptosis. Food & Function. 9(1). 87–95.
Yuan. Tao. Yuanqing Ding. Chunpeng Wan. Liya Li. Jialin Xu. Ke Liu. Angela Slitt. Daneel Ferreira. Ikhlas A. Khan. and Navindra P. Seeram. (2012). Antidiabetic Ellagitannins from Pomegranate Flowers: Inhibition of α-Glucosidase and Lipogenic Gene Expression. Organic Letters. 14(20). 58–61.
Sun Jian. Qu Chao. Wang Yajun. Huang Hui . Zhang Mingrui . Li Hongyan . Zhang Yejun . Wang Yang. and Zou Wei. (2016). PTP1B. A Potential Target of Type 2 Diabetes Mellitus. Mol Biol. 5(4). 1-6.
Downloads
Published
Issue
Section
License
The copyright of the received article shall be assigned to the publisher of the journal. The intended copyright includes the right to publish the article in various forms (including reprints). The journal maintains the publishing rights to published articles. Therefore, the author must submit a statement of the Copyright Transfer Agreement.*)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
In line with the license, authors and any users (readers and other researchers) are allowed to share and adapt the material. In addition, the material must be given appropriate credit, provided with a link to the license, and indicated if changes were made. If authors remix, transform or build upon the material, authors must distribute their contributions under the same license as the original.
*) Authors whose articles are accepted for publication will receive confirmation via email to send a Copyright Transfer Agreement.
